Get started
Author

Şeymanur Ala Enli

Observed name: Şeymanur ALA ENLİ
ORCID: 0000-0003-2568-7155
Observed ORCID: 0000-0003-2568-7155
OpenAlex ID: A5083402212
Semaphorin 3A levels in vascular and nonvascular phenotypes in systemic sclerosis
2023 · Mehmet Kayaalp, Abdulsamet Erden, et al. · Laboratory Medicine · 6
Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers: National, Comparative, Observational Study ( TOG / GI ‐ SAFRADJU ‐2501)
2026 · Erman Akkus, Mehmet Kayaalp, et al. · International Journal of Cancer
Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO)
2026 · Erman Akkus, Mehmet Kayaalp, et al. · JCO Global Oncology
Serum Semaphorin 3A Levels in Patients with Behçet’s Disease with and without Vascular Involvement
2025 · Merve Çağlayan Kayaalp, Abdulsamet Erden, et al. · Bratislavské lekárske listy/Bratislava medical journal
Ailesel Akdeniz Ateşi (AAA) Hastalarında Semaforin 3a Düzeyi’nin Kolşisin Direnci İle İlişkisinin Değerlendirilmesi
2022 · Şeymanur ALA ENLİ · AYBU AVESIS
PDF
Works count: 5
Citation count: 6
H-index: 1
I10-index:
Year
Topic
Type